Metatropic dwarfism: Clinical Trials

2 completed, 1 terminated, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 2, Terminated 1, Unknown 1
Phase 2	1	Unknown 1

Follow Metatropic dwarfism: new trials by email Literature Review of Metatropic dwarfism trials Research Report on Metatropic dwarfism

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma CC-90010, Temozolomide, Radiotherapy - Glioblastoma	Phase 1	Terminated	Celgene	184	2020-07-10	2024-07-26
Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue Everolimus - Neuroendocrine Tumors	Phase 1 / Phase 2	Unknown	King Faisal Specialist Hospital & Research Center	30	2012-12-01	2018-08-14
A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males ASP8477, omeprazole, Placebo - Pharmacokinetics of ASP8477, Pharmacodynamics of ASP8477	Phase 1	Completed	Astellas Pharma Europe B.V.	72	2010-11-01	2014-08-20
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors Genz-644282 (28-day dosing schedule), Genz-644282 (21-day dosing schedule) - Solid Tumors	Phase 1	Completed	Genzyme, a Sanofi Company	87	2009-07-01	2014-03-19

Narrower conditions

Glioblastoma (1)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Astrocytoma (1)  ·  Glioma (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Neuroepithelial (1)

Interventions

ASP8477 (1)  ·  Everolimus (1)  ·  Genz-644282 (1)  ·  Omeprazole (1)  ·  Radiotherapy (1)  ·  Temozolomide (1)

Sponsors

Astellas Pharma Europe B.V. (1)  ·  Celgene (1)  ·  Genzyme, a Sanofi Company (1)  ·  King Faisal Specialist Hospital & Research Center (1)

Countries

United States (2)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Ali Aljubran, MD (1)  ·  Fazal Hussain, MD (1)

Results publications

PMID 36455228

NIH funding

2009 (1), 2019 (1)